320 related articles for article (PubMed ID: 23266657)
1. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
Shroff GR; Solid CA; Herzog CA
JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
[No Abstract] [Full Text] [Related]
2. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
3. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
Yu HC; Tsai YF; Chen MC; Yeh CH
Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
5. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the CHA
Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ
Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds.
Badi MK; Vilanilam GK; Gupta V; Barrett KM; Lesser ER; Cochuyt JJ; Hodge DO; Brott TG; Meschia JF
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2159-2167. PubMed ID: 31103554
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).
Lakshminarayan K; Solid CA; Collins AJ; Anderson DC; Herzog CA
Stroke; 2006 Aug; 37(8):1969-74. PubMed ID: 16809573
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: effect of diabetes.
Shroff GR; Solid CA; Bloomgarden Z; Halperin JL; Herzog CA
J Diabetes; 2017 Feb; 9(2):115-122. PubMed ID: 26929264
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
Winkelmayer WC; Liu J; Setoguchi S; Choudhry NK
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2662-8. PubMed ID: 21959598
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for stroke prevention in a Medicare population with atrial fibrillation.
Miranda LS; Turkel RA; Ahmed O; Dent M; Dion C
J Fla Med Assoc; 1997; 84(4):227-31. PubMed ID: 9342908
[No Abstract] [Full Text] [Related]
12. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Garwood CL; Corbett TL
Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and therapeutic implications of cerebral microbleeds in patients on warfarin.
Ding D
Clin Neurol Neurosurg; 2013 Dec; 115(12):2553-4. PubMed ID: 24139629
[No Abstract] [Full Text] [Related]
14. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
Yaghi S; Mistry E; Liberman AL; Giles J; Asad SD; Liu A; Nagy M; Kaushal A; Azher I; Mac Grory B; Fakhri H; Brown Espaillat K; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Scher E; Trivedi T; Lord A; Furie K; Keyrouz S; Nouh A; Leon Guerrero CR; de Havenon A; Khan M; Henninger N
Stroke; 2020 Sep; 51(9):2724-2732. PubMed ID: 32757753
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic risk management in paroxysmal atrial fibrillation after brain haemorrhage.
Sanna T; Di Lazzaro V
Int J Stroke; 2011 Feb; 6(1):92-3. PubMed ID: 21205251
[No Abstract] [Full Text] [Related]
16. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
Pieri A; Lopes TO; Gabbai AA
Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
[No Abstract] [Full Text] [Related]
17. Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
Hylek EM; Magnani JW
Europace; 2008 Jan; 10(1):3-5. PubMed ID: 18039690
[No Abstract] [Full Text] [Related]
18. Oral anticoagulation and stroke in atrial fibrillation.
Boos CJ
N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
[No Abstract] [Full Text] [Related]
19. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
20. Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery.
Schulman S; Cybulsky I; Delaney J
Thromb Res; 2015 May; 135(5):841-5. PubMed ID: 25776468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
